Invasive Squamous Cell Carcinoma of the Cervix: A Review of Morphological Appearances Encountered in Human Papillomavirus-associated and Papillomavirus-independent Tumors and Precursor Lesions
- PMID: 37638549
- PMCID: PMC10841279
- DOI: 10.1097/PAP.0000000000000411
Invasive Squamous Cell Carcinoma of the Cervix: A Review of Morphological Appearances Encountered in Human Papillomavirus-associated and Papillomavirus-independent Tumors and Precursor Lesions
Abstract
Cervical cancer is the fourth most common cancer among women globally. Historically, human papillomavirus (HPV) infection was considered necessary for the development of both precursor and invasive epithelial tumors of the cervix; however, studies in the last decade have shown that a significant proportion of cervical carcinomas are HPV-independent (HPVI). The 2020 World Health Organization (WHO) Classification of Female Genital Tumors separates both squamous cell carcinomas (SCCs) and endocervical adenocarcinomas (ECAs) by HPV status into HPV-associated (HPVA) and HPVI tumors. The classification further indicates that, in contrast to endocervical adenocarcinomas, HPVI and HPVA SCCs cannot be distinguished by morphological criteria alone and suggests that HPV testing or correlates thereof are required for correct classification. Moreover, while HPVA SCC precursor lesions (ie, high-grade squamous intraepithelial lesion) are well known and characterized, precursors to HPVI SCCs have only been described recently in a small number of cases. We studied 670 cases of SCCs from the International Squamous Cell Carcinoma Project (ISCCP) to analyze the reproducibility of recognition of invasive SCC growth patterns, presence of lymphovascular space invasion, tumor grade, and associations with patient outcomes. Consistent with previous studies, we found histologic growth patterns and tumor types had limited prognostic implications. In addition, we describe the wide morphologic spectrum of HPVA and HPVI SCCs and their precursor lesions, including tumor growth patterns, particular and peculiar morphologic features that can lead to differential diagnoses, and the role of ancillary studies in the diagnosis of these tumors.
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
Outside the current work, A.I. reports consulting fees from Mylan. The remaining authors have no conflicts of interest to disclose.
Figures








Similar articles
-
Cervical Human Papillomavirus-Independent Squamous Cell Carcinoma: A Clinicopathological Review and Outcomes Analysis Compared With Human Papillomavirus-Associated Squamous Cell Carcinoma.Mod Pathol. 2025 Jun;38(6):100742. doi: 10.1016/j.modpat.2025.100742. Epub 2025 Feb 24. Mod Pathol. 2025. PMID: 40010435
-
Incidence and Clinicopathologic Characteristics of Human Papillomavirus-independent Invasive Squamous Cell Carcinomas of the Cervix: A Morphologic, Immunohistochemical, and Human Papilloma-Virologic Study of 670 Cases.Am J Surg Pathol. 2023 Dec 1;47(12):1376-1389. doi: 10.1097/PAS.0000000000002122. Epub 2023 Sep 13. Am J Surg Pathol. 2023. PMID: 37702216 Free PMC article.
-
Retrospective analysis of cytology and high-risk HPV testing in 1067 endocervical adenocarcinomas and precursor lesions.Cancer Cytopathol. 2024 Jun;132(6):340-347. doi: 10.1002/cncy.22802. Epub 2024 Feb 19. Cancer Cytopathol. 2024. PMID: 38373111
-
Recent advances in invasive adenocarcinoma of the cervix.Virchows Arch. 2019 Nov;475(5):537-549. doi: 10.1007/s00428-019-02601-0. Epub 2019 Jun 17. Virchows Arch. 2019. PMID: 31209635 Free PMC article. Review.
-
Carcinomas of the Uterine Cervix: Comprehensive Review With An Update on Pathogenesis, Nomenclature of Precursor and Invasive Lesions, and Differential Diagnostic Considerations.Adv Anat Pathol. 2021 May 1;28(3):150-170. doi: 10.1097/PAP.0000000000000300. Adv Anat Pathol. 2021. PMID: 33825718 Review.
Cited by
-
HPV-independent squamous sell carcinoma of cervix: a clinicopathological, immunohistochemical, and molecular analysis of six cases.Virchows Arch. 2025 May 10. doi: 10.1007/s00428-025-04113-6. Online ahead of print. Virchows Arch. 2025. PMID: 40347270
-
Mapping the immunological landscape and emerging immunotherapeutic strategies in cervical cancer: a comprehensive review.Front Oncol. 2025 Jul 10;15:1620501. doi: 10.3389/fonc.2025.1620501. eCollection 2025. Front Oncol. 2025. PMID: 40708940 Free PMC article. Review.
References
-
- WHO Classification of Tumours Female Genital Tumours. 5 ed. WHO Classification of Tumours. International Agency for Research on Cancer; 2020.
-
- Kurman RJ, Carcangiu ML, Herrington CS. World Health Organisation classification of tumours of the female reproductive organs. 4 ed. World Health Organization classification of tumours Lyon: International agency for research on cancer; 2014.